News
-
-
PRESS RELEASE
Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic presents new clinical, biomarker, and preclinical data for Vidofludimus Calcium in four poster presentations at MSToronto2026. Significant findings supporting treatment effects and disease progression in multiple sclerosis patients -
-
-
-
PRESS RELEASE
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic to present new clinical, biomarker, and preclinical data on Vidofludimus Calcium at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting. New findings showcased to deepen understanding of multiple sclerosis treatment -
-
-
-